CCK-8 Cell Proliferation Activity Assay: Principle, Protocol, and Applications

The CCK-8 cell proliferation activity assay is a rapid, highly sensitive colorimetric method widely used to quantify cell viability, proliferation, and cytotoxicity in vitro. Based on the reduction of the WST-8 tetrazolium salt by intracellular dehydrogenases, the CCK-8 assay delivers accurate, reproducible results with a simple one-step procedure. This article provides a comprehensive technical overview of the assay principle, testing samples, testing items, methodology, applications, and frequently asked questions.

Technical Overview

The CCK-8 (Cell Counting Kit-8) assay is a colorimetric technique designed to measure cell proliferation and cell viability based on the metabolic activity of living cells. The assay reagent contains the water-soluble tetrazolium salt WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium sodium salt), which is reduced by intracellular dehydrogenases present in viable cells to generate an orange-colored, water-soluble formazan dye. The quantity of formazan produced is directly proportional to the number of living cells in the culture.

The concentration of the formazan dye is determined by measuring the absorbance at 450 nm using a microplate reader, with a reference wavelength between 600 and 700 nm recommended for improved accuracy. Compared with the traditional MTT assay, the CCK-8 assay offers several advantages: the formazan product is water-soluble and does not require organic solvents for dissolution, the reagent exhibits lower cytotoxicity allowing continuous cell monitoring, and the detection sensitivity is significantly higher. These features make CCK-8 one of the most convenient and reliable methods for high-throughput cell proliferation and drug cytotoxicity analysis.

Testing Samples

Adherent Cell Lines

Adherent cell lines, including tumor cell lines such as HeLa, MCF-7, A549, HepG2, HCT116, and non-tumor lines such as HEK293, NIH-3T3, and L929 fibroblasts, are routinely analyzed using the CCK-8 assay. These cells are typically seeded into 96-well plates and allowed to attach before treatment and detection.

Suspension Cell Lines

Suspension-growing cells, including leukemia cell lines (K562, Jurkat, HL-60), lymphoma cell lines, and hybridoma cells, can be assayed directly in culture without attachment steps. Gentle mixing before absorbance measurement ensures uniform distribution of the formazan product.

Primary Cells and Stem Cells

Primary cells isolated from animal or human tissues, as well as mesenchymal stem cells and induced pluripotent stem cell derivatives, can be evaluated for proliferative capacity and viability using the CCK-8 method, provided that appropriate seeding densities and culture conditions are optimized.

Drug-Treated or Stimulated Cells

Cells exposed to candidate pharmaceutical compounds, natural product extracts, nanoparticles, cytokines, siRNA, or gene overexpression constructs are key sample types for assessing treatment effects on proliferation and survival.

Testing Items

The CCK-8 assay supports a broad range of quantitative testing items in cell biology and pharmacological research:

• Cell viability quantification and determination of the proportion of living cells after treatment
• Cell proliferation kinetics and construction of cell growth curves over multiple time points
• Cytotoxicity evaluation of compounds, environmental factors, or physical stimuli
• Drug sensitivity testing and dose-response analysis for IC50 calculation
• Cell-mediated cytotoxicity assessment in immunological studies
• Biocompatibility screening of medical devices, biomaterials, and nanoparticle formulations

Testing Methods

Standard Assay Protocol

The CCK-8 assay follows a simple, one-step workflow suitable for 96-well or 384-well plate formats. A typical procedure is described below:

• Seed cells into a 96-well plate at an optimized density, commonly 1,000 to 10,000 cells per well in 100 µL of complete medium, and prepare a blank well containing medium only
• Incubate the plate at 37°C in a humidified incubator with 5% CO2 until cells adhere, typically 12 to 24 hours for adherent lines
• Add test compounds or treatments at graded concentrations and incubate for the desired exposure period, commonly 24, 48, or 72 hours
• Add 10 µL of CCK-8 reagent to each well, taking care to avoid introducing bubbles
• Incubate the plate for 1 to 4 hours at 37°C, with the optimal incubation time determined by the cell type and metabolic activity
• Measure the absorbance at 450 nm using a microplate reader, using the blank well for background correction

Experimental Controls

Proper controls are essential for reliable data interpretation. The blank control contains medium plus CCK-8 reagent without cells and is used to subtract background absorbance. The negative control contains untreated cells and represents 100% viability. A positive control treated with a known cytotoxic agent, such as a cytotoxic drug, validates the assay responsiveness. Replicate wells, typically three to six per condition, should be included to ensure statistical robustness.

Data Analysis

Cell viability is calculated as the percentage of the absorbance of treated wells relative to the untreated control after blank subtraction. Cell proliferation rates can be compared across time points to generate growth curves. Dose-response data are fitted using nonlinear regression models to calculate the IC50 value, defined as the concentration of test compound that inhibits cell growth by 50%. Absorbance values within the linear range of the standard curve should be confirmed by a cell number titration experiment to guarantee quantitative accuracy.

Technical Considerations

Several factors influence the accuracy of CCK-8 results. Cell density must fall within the linear detection range to avoid signal saturation. Edge effects caused by evaporation in outer wells can be mitigated by filling perimeter wells with sterile PBS or medium. Compounds with inherent color or reducing activity, such as ascorbic acid or certain antioxidants, may interfere with absorbance readings and require compound-only background controls. Bubbles introduced during reagent addition should be removed before measurement, as they scatter light and distort readings.

Applications

The CCK-8 assay is extensively applied across academic research, pharmaceutical development, and industrial biocompatibility testing. In drug discovery, it serves as a primary screening tool for identifying antitumor, antimicrobial, and anti-inflammatory compounds with growth-inhibitory activity. In oncology research, it is used to compare the proliferation rates of cancer cell lines, evaluate the efficacy of chemotherapeutic agents, and investigate resistance mechanisms. In toxicology, CCK-8 enables assessment of chemical safety, nanoparticle toxicity, and environmental pollutant effects on mammalian cells. In biomaterials science, the assay supports ISO 10993 biocompatibility evaluation of medical devices and implant materials. Additional applications include evaluating the effects of gene knockdown or overexpression on cell growth, assessing the proliferative response to growth factors, and optimizing cell culture conditions for industrial cell line development.

FAQ

What is the difference between the CCK-8 assay and the MTT assay?

Both assays measure cellular dehydrogenase activity, but the CCK-8 assay uses WST-8, which is reduced to a water-soluble formazan that can be read directly without a dissolution step. MTT produces an insoluble formazan crystal that requires DMSO or isopropanol solubilization. CCK-8 is also more sensitive, less toxic to cells, and better suited for high-throughput screening.

Can the same plate be read at multiple time points?

Yes. Because CCK-8 reagent is minimally toxic, the absorbance of the same plate can be measured repeatedly at different incubation times or time points, which is useful for generating proliferation curves. However, repeated removal of the plate from the incubator should be minimized to avoid temperature fluctuations and contamination.

What is the optimal incubation time with the CCK-8 reagent?

The optimal incubation time varies by cell type, density, and metabolic activity. Generally, 1 to 4 hours is sufficient, and a pilot experiment should be performed to determine the time at which absorbance falls within the linear detection range while remaining below saturation.

How are colored or reducing compounds handled?

Test articles that are colored or chemically reducing can generate background signal. Include wells containing the compound plus CCK-8 reagent without cells, and subtract this background absorbance from the corresponding treatment wells before calculating viability.

Why are my outer wells showing inconsistent results?

Inconsistency in peripheral wells is usually caused by evaporation, known as the edge effect. Filling unused edge wells with sterile PBS or water and maintaining stable humidity in the incubator effectively reduces this problem.

What cell density should be used for the assay?

A preliminary titration is recommended to identify the density range in which absorbance increases linearly with cell number. As a general guideline, 1,000 to 10,000 cells per well in 96-well plates works for most cell lines, with faster-growing cells seeded at lower densities and slower-growing primary cells seeded at higher densities.